Related Experiment Video
Updated: Jul 15, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss
1Department of Medicine, University of Liverpool.
Abstract:
Nephrotoxicity in association with 5-aminosalicylic acid therapy is well recognised. In this patient the nephrotoxicity only became apparent after severe weight loss had occurred in association with nephrogenic diabetes insipidus. The patient aged 26 with ulcerative colitis received resin coated mesalazine (Asacol) 1200 mg/day and lost 12 kg in weight over a four month period, only complaining of thirst towards the end of this period.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management
Diabetes Insipidus I: Introduction
Diabetes Insipidus II: Pathophysiology
Type I Diabetes III: Clinical Manifestations

